Future of Personalised Medicine: Quality Assurance of Oncology Biomarker Testing is Essential KU Leuven
Future of personalised medicine: quality assurance of oncology biomarker testing is essentialTumour specific mutations play an increasing role in the selection of targeted therapy. However testing for
these mutations is not straightforward and errors occur. This could lead to a denial of treatment to patients who
would actually benefit from it, or a superfluous use of high-priced therapeutic agents and unnecessary sideeffects in ...